Abcam PLC
LSE:ABC
Abcam PLC
Total Current Assets
Abcam PLC
Total Current Assets Peer Comparison
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abcam PLC
LSE:ABC
|
Total Current Assets
£257.8m
|
CAGR 3-Years
14%
|
CAGR 5-Years
12%
|
CAGR 10-Years
18%
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Total Current Assets
$315.1m
|
CAGR 3-Years
204%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Total Current Assets
$275.3m
|
CAGR 3-Years
12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Total Current Assets
$516m
|
CAGR 3-Years
34%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Total Current Assets
£528.8m
|
CAGR 3-Years
51%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Total Current Assets
£277.4m
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
5%
|
See Also
What is Abcam PLC's Total Current Assets?
Total Current Assets
257.8m
GBP
Based on the financial report for Jun 30, 2022, Abcam PLC's Total Current Assets amounts to 257.8m GBP.
What is Abcam PLC's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
18%
Over the last year, the Total Current Assets growth was -19%. The average annual Total Current Assets growth rates for Abcam PLC have been 14% over the past three years , 12% over the past five years , and 18% over the past ten years .